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Abstract: Background: Nowadays, the functional foods represent one the most promising, interesting and 
innovative areas in the food industry. Various components are being added to foods in order to render 
them functional. Methods: One example of these components are plant naturally occurring phenolic 
compounds, which are associated with a high antioxidant capacity and thus with benefits in relation to 
human health. Results: However, despite the huge number of scientific studies and patents on this topic 
and their natural presence in foods, namely in the ones from plant origin, there are still few marketable 
products enriched with these compounds. The commercialization of this type of functional products needs 
to go through various regulations, proving that they are safe and present the ascribed health benefits, 
conquering the target audience. In this review the growing interest of industry and consumers’ appetence 
for functional foods and nutraceuticals is highlighted, focusing especially phenolic compounds. 
Conclusion: Although several published works show the multitude of bioactive properties of these 
compounds, ensuring their use as bioactive ingredients in food, they present inherent stability issues 
needing to be solved. However, considerable research is presently ongoing to overcome this problem, 
making viable the development of new products to be launched in the market. 
Keywords: Phenolic compounds; nutraceuticals; functional foods; health benefits; consumers. 
 
1. INTRODUCTION  
The scientific community and the food industry have developed an increasing interest for 
functional and nutraceutical properties of some nutrients and natural compounds, in viewing of their 
incorporation in added-value foodstuffs. These enrichments can use natural sources from plant, 
mushroom or animal origin, but also synthetic compounds with improved biological activities. Some 
examples of bioactive ingredients are vitamins, amino acids, fibers, fatty acids, and phenolic compounds 
(PC) [1]. The bioactive ingredients obtained from natural sources have been used since ancient times all 
over the world with the conviction that guarantee medicinal properties in fighting certain diseases [2,3]. 
Phenolic acids, flavonoids and stilbenes are some of the PC classes, widely distributed among 
medicinal herbs and dietary plants. These compounds present a broad range of bioactivities such as 
antioxidant, antimicrobial, anti-inflammatory, antitumoral and hepatoprotective effects. Some PC exhibit 
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high antioxidant activity as individual compounds, while others, depend on synergisms to undergo 
bioactive effects [4]. The antioxidant activity of these compounds is related with their chemical structure, 
generally depending on hydroxyl groups’ number and position, glycosylation or other types of 
substitution [5]. Furthermore, PC are involved in the neutralization of reactive species that attack cell 
molecules and in several diseases prevention related to oxidative and nitrosative stress such as cancer, 
cardiovascular diseases, atherosclerosis, neurological disorders, hypertension, and diabetes mellitus, 
among others [4].  
There are also many studies describing the antifungal activity of PC, expressed through an 
interaction with the lipid bilayer of the fungi cell membrane (disruption of the membrane integrity or 
intercalation into cell wall and/or DNA - Deoxyribonucleic Acid) [6]. These compounds have also shown 
antimicrobial activity, by delaying or inhibiting the growth of pathogenic and/or toxin-producing 
microorganisms in food, as also by minimizing the incidence of foodborne diseases caused by food 
spoilage bacteria and fungi [7]. The numerous scientific studies with PC also described their anti-
inflammatory properties [8,9].  During the inflammation process it is observed the formation of various 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) that result in increased activity of 
pro-inflammatory agents. The PC have ability to reduce or prevent the prejudicial effects in human 
organism through the reduction of pro-inflammatory enzymes [10]. 
Cancer is a global concern which causes millions of deaths each year, even in the most developed 
countries [11]. Despite major advances in the treatment of patients with cancer these remain insufficient 
to reduce suffering and mortality [12]. In traditional medicine, the plants represent an important ally in 
the treatment of various diseases. Currently, natural compounds represent an important fraction in the 
composition of new anticancer drugs developed by the pharmaceutical industry [13,14]. Several studies 
have concluded that bioactive ingredients from plants may have anticancer effects in cell lines but also in 
murine models, including being more efficient than synthetic compounds [15]. There are several toxicity 
problems associated with the use of synthetic molecules in the treatment of cancer. Alternatively, some 
natural compounds isolated from plants can be administered without any side effect or toxicity to patients 
[15]. The potential antitumoral effects of PC have been intensively studied, both with tumor cell lines and 
by using in vivo models and human trials [15]. PC have shown the capacity to induce apoptosis by 
arresting cell cycle, regulate carcinogen metabolism and ontogenesis expression, inhibit DNA binding 
and cell adhesion, migration, proliferation or differentiation, and block signaling pathways [16]. 
Additionally, PC have been intensively studied in regard to their hepatoprotective capacity against 
chemically induced damage, either in vivo or in vitro. These compounds seem to overcome liver injuries 
often caused by oxidative reactions that promote lipid peroxidation in hepatic tissues; among these 
constituents, flavonoids and phenolic acids have received special attention for their high antioxidant 
activity supporting the observed hepatoprotective effects [17]. 
Due to their characteristics, foods rich in PC have been considered functional foods. Although the 
existence of earlier reports (1985-1999), a significant growing interest for this type of products, either 
from academia (through research articles and scientific reviews) or industry (through patents), was 
observed since 2000, indicating an increasing tendency (Figure 1). 
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In this review article, the sector of functional foods and nutraceuticals was analyzed, highlighting 
the particular case of the use of PC as bioactive ingredients, either in functional foods or in nutraceutical 
formulations. Examples of products already available in the market will be also given. 
 
2. THE GROWING SECTOR OF FUNCTIONAL FOODS AND NUTRACEUTICALS 
 
2.1. Definitions 
The term "functional food" first appeared in the 80s in Japan in reference to food products 
enriched with special components that have beneficial physiological effects [18,19]. 
A food can be classified as "functional" if, beyond adequate nutritional effects, it demonstrates 
benefits in one or more target functions in the human body relevant to improve health and well-being 
and/or to reduce risk disease. These foods can be natural or unmodified, or foods to which a component 
has been added or removed by technological means. They can be naturally ingested in diet. Thus, 
functional foods can be classified as: 1) Non-altered products, foods which naturally contain a high level 
of nutrients/health promoting compounds (e.g. eggs with increased omega-3); 2) Fortified products, foods 
in which components content is increased (e.g. fruit juices fortified with vitamin C); 3) Enriched 
products, foods to which a component with certain benefits was added (e.g. margarine with plant sterol 
ester, pro and prebiotics); 4) Altered products, i.e. foods in which a specific component was removed or 
substituted (e.g. addition of fibers as fat releasers in meat or ice cream products) [20-22]. 
Presently there is no definition or legislation universally accepted for functional foods [23]. 
However, this is one of the most interesting and active research and innovation areas for the food 
industrial sector [24]. Its market share is growing worldwide, and new products are being continuously 
launched [19]. Some commercial products with beneficial health functions can be already found; among 
them the most demanded by the consumers are: probiotic liquid yogurt containing Lactobacillus casei 
Imunitass® cultures (brand Actimel® from Danone®, France), solid yogurt with Bifidus ActiRegularis® 
(brand Activia® from Danone®, France), snacks and cereal bars with natural fibers and extra minerals and 
vitamins (Snack brand Fibra® from Celigüeta®, Spain), dairy drink with L. casei Shirota (brand Yacult® 
from Yacult®, Japan) and yogurt containing pre- and probiotics and omega-3 (brand Vitality®, Müller®, 
Germany).  
Among others, dairy products have many reported health benefits. They are widely consumed and 
appreciated by consumers and, thus, represent an important vehicle for functional foods development. 
Moreover, the dairy industry is considered one of the most important and dynamic sectors of the food 
industry. This sector is in permanent innovation trying to develop new products with added value. 
Accordingly, an increasing variety of new dairy products has been observed to satisfy consumer’s 
demand for healthier products, including low-fat (e.g. skimmed and semi-skimmed milk) and the high-
protein content ones [25].  
In turn, nutraceuticals can be defined as diet supplements containing bioactive compounds or 
extracts, prepared from raw matrices and used in unit dosage forms such as tablets, capsules or liquids. 
Thus, the bioactive agent is in this case more concentrated, and otherwise, it cannot be obtained from the 
normal food intake to present positive physiological effects on the human body [26,27]. Nowadays, the 
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use of nutraceutical formulations in dietary supplements as a complement to prevent some diseases is 
very common [28]. Some authors classified nutraceuticals in traditional (substances naturally contained in 
foods) and non-traditional (substances added to foods by bio-engineering actions) [29]. Nutraceuticals 
concept is relatively recent, only appearing in the 90s, but consumer’s demand for new, better and safer 
food products is pressing food industry for a constant innovation and product’s offer increase [30]. 
The processing of nutraceuticals can follow four steps: pretreatment (includes homogenization, 
grinding, milling, maceration, and drying), extraction (in which the selection of a method depends of 
factors such as the source and type of bioactive compound to be extracted, desired recovery and 
operational requirements), isolation/purification, and encapsulation [31]. 
When processed under controlled conditions (i.e. under moderate temperature and pressure, and by 
avoiding light exposure), nutraceuticals can suffer minor deterioration, nevertheless extreme pH 
conditions or enzymes presence, typical of intestinal tract, can significantly affect their bioavailability 
[32,33]. 
It is a common pitfall the confusion between nutraceuticals and functional foods definition; even 
in the literature a nutraceuticals is defined as any food or part of it as long as their beneficial health and 
nutritional claims can be proved scientifically [28]. However, some authors consider nutraceuticals as 
components that are often consumed in unit dose forms such as tablets, capsules or liquids [27,34]. 
Sometimes nutraceuticals and functional foods are produced with the same ingredients but in different 
forms [35]. 
Nowadays, foods that indicate improvement of consumer’s health have to go through a large 
control mainly in what concerns labeling information. The European Union (EU) is facing, since 2012, 
new legislation that requires a rigorous standard of scientific evidence for making health claims on foods, 
beverages and dietary supplements [34,36]. However, these foods are still not included in a specific food 
category [37]. On the other hand, in the United States of America (USA), Food and Drug Administration 
(FDA) defines the products categories depending on its characteristics obeying several safety issues, 
health claims, labelling and good manufacturing practices [38]. 
 
2.2. Hot scientific topics and consumer’s increasing demand  
Behavioral and socio-demographic trends, particularly the existence of different eating habits 
motivate the existence of different national policies to promote public health. This, together with 
differences related to cultural traditions, constitute the main challenges towards the successful 
introduction of functional products on the market. Therefore, for a better consumer’s acceptance a strong 
enlightenment about "functional food" concept is needed. Some studies have shown that cognitive, 
motivational and attitudinal determinants of consumer’s acceptance of functional foods vary considerably 
in different countries [39]. However, there has been a huge change in eating habits, i.e., in addition to the 
nutritional and sensory properties, food seems to play an important role in health maintenance and disease 
prevention [40,41]. Therefore, functional foods have gained prominence, becoming its development a hot 
research area for both academia and industry [36].  
Functional foods have been growing in the market over time. Some entities, like researchers and 
professionals, agree that the market for functional foods is achieving a raising growth worldwide 
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[39,40,42]. Their global market was estimated at about 625 billion dollars in 2012 [43], being the three 
main markets represented by Japan followed by the USA and finally EU. These three markets contribute 
to 90% of total sales [19]. Apart from its pioneer role (functional foods started to be a reality in this 
country), Japan is also the strongest market worldwide; in only 10 years (1988-1998) more than 1700 
functional food products were released [19,44]. This market showed an average growth rate of 9.6% per 
year during the 90s, and their related industry was estimated to a turnover of approximately 12 billion 
dollars in 2003 [39]. 
The USA has the second largest market for functional foods, with a turnover of 10.5 billion dollars 
in 2003. In this country the market share for functional foods is around 2-3% and is constantly growing 
[39,40]. The ever-growing functional foods and drinks market increased 1.5 fold globally, reaching 24.2 
billion dollars in 2010 and 29.8 billion dollars in 2014 [36]. 
Europeans still show some skepticism in relation to functional foods, partly due to suspected 
safety of these food products, but also because of their productive process [39]. The demand for 
functional foods in the EU varies due to food and cultural traditions, being higher in Northern Europe 
than in Mediterranean countries. United Kingdom (2.6 billion dollars), Germany (2.4 billion dollars), 
France (1.4 billion dollars) and Italy (1.2 billion dollars) stand as the main markets [19,39]. However, 
many other markets, such as Netherlands, Spain, Poland and Hungary, are experiencing high growth rates 
[199,39, 45-47]. 
In the EU, as well as in Japan, the market for functional foods is dominated by probiotics, and 370 
products were launched worldwide in 2005 [48]. The lactic acid bacteria (LAB) and bifidobacteria are the 
most studied and used for new product development, for example in Italy, the most important product in 
functional food market is the called “health yogurt”; it represented in 2008 a growth rate of 6.3% per 
year, thus reaching 560 million euros of sales, corresponding to almost 4% of the whole Italian sector 
[19]. 
Functional foods have added benefits if compared to the traditional ones. The functionality of 
these foods is derived from the presence of bioactive ingredients. Typically, the functional ingredients 
incorporated into foods aimed at prevent some chronic diseases, as well as promote better physical and 
psychic well-being; therefore, health concerns are the most significant factors influencing consumers. 
According with Arvanitoyannis & Houwelingen-Koukaliaroglou [49], people from different countries 
seek for different characteristics in food. Thus, Americans search primarily functional food for weight 
loss and cholesterol lowering, while EU, which comprises the major consuming countries, wants mainly 
health prevention food. In particular, United Kingdom consumes foods to promote bone and teeth health, 
Germany to enhance/stimulate the immunologic system and bone health; and lastly, in France, the 
functional foods are consumed to stimulate cholesterol lowering and generally increase resistance to 
disease. 
 
2.3. Main bioactive ingredients and food sectors  
The acceptance of a specific functional ingredient is intimately related to consumer's knowledge of 
its beneficial health effects. Thus, the functional ingredients known since a longer period, such as 
minerals, vitamins, fibers, and fatty acids reach considerably higher acceptance rates than the newer ones, 
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such as PC. In this case, consumers do not recognize the health benefits associated to this last group 
[22,25]. 
Vitamins and minerals are defined as nutrients and have recommended ingesting doses in order to 
produce the desired effect [50,51]. Vitamins are complex organic substances that are required in small 
quantities for a healthy body. With the exception of vitamin D, all other vitamins are not produced by the 
organism, having to be obtained through the diet. Vitamins play important biological functions, such as in 
the role of co-factors in enzymatic activity, as antioxidants or as pro-hormone [49]. Milaneschi et al [52] 
described that there is a correlation between vitamin E and the onset of depression in the elderly. This 
study was conducted with 531 women and 432 men aged from 65 years, being found a direct relationship 
between 25-hydroxyvitamin D deficiency and depression [25]. Dietary fibers are defined as non-
digestible carbohydrates that are present in vegetal sources. The fibers can be classified as water soluble 
or insoluble, and may alter the nature of the gastrointestinal tract contents, changing the way nutrients and 
chemicals are absorbed. Examples such inulin and several other oligosaccharides stimulate bifidobacteria 
growth, increasing gut health (decreased intestinal transit) and immunity. Minerals are essential to body 
function, since they are involved in metabolic processes such as muscle contraction, nerve impulses 
transmission, water maintenance, acid-base balance, and catalysis of other biological reactions [49].  
PC, compounds naturally present in plants, are among the most interesting bioactives due to its 
great antioxidant capacity associated with benefits in relation to human health, namely in the prevention 
of some common diseases [53]. This type of compounds have been widely studied in recent years, and 
further incorporated into different food matrices in order to render them functional [54,55]. 
Currently, food industry has developed different fortified food products to meet consumer’s 
demands, who are increasingly concerned with their feeding habits. Therefore, new functional food 
products have been developed by introducing the active ingredient at the correct dosage, and without 
changing organoleptic and texture properties, as appreciated by the consumers [30,56].  
Functional foods have been developed in virtually all food categories. Functional cereal 
components such as beta-glucan (mainly from oat and barley), have been used in dairy bakery industries 
to manufacture low-fat ice creams [57]. The bakery products still represent a small share in the functional 
foods industry (just over 13% in 2000s), comparatively with dairy products, which holds the largest share 
of the functional food market [22,40]. However, a growth in this sector has been observed, and there are 
some successful examples in the market. This is the case of Unilever® that produced in 2003 the "Blue 
Band Goede Start®" as the first white bread enriched with functional elements (fiber, vitamins B1, B3 and 
B6, iron, zinc and inulin), only available on whole wheat bread [58]. 
Eggs, a fatty acids rich food highly appreciated by consumers, are another example that raised 
interest in the food industry to make them functional. In the United Kingdom, the Freshlay Foods® 
produced the VITA Eggs®, described as eggs enriched with omega-3 fatty acids conjunctly with 
antioxidants and other vitamins (D, E, B12 and folic acid). Also in Belgium, there is a similar successful 
case: the Columbus® by Belovo®, eggs enriched in omega-3 and vitamin E, currently exported all over the 
world and whose annual production is estimated to be over 50 million [22]. 
In EU, the market of non-alcoholic beverages enriched with vitamins (especially A, C and E), and 
other bioactive components, is still running at a modest scale. However, its growth is rising exponentially 
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bringing to market various highly appreciated products. In particular, drinks with soy and omega-3 (to 
lower cholesterol), drinks with lutein (to improve vision) and drinks with calcium and insulin (to improve 
health issues), can be cited as examples [59]. Germany is a successful representative of this food category 
mainly due to the success of ACE® drinks, with a sales income of many millions of dollars in the last 
decade [22]. Another example of success, especially for its great contribution to the Estonian economy, is 
the Largo® beverages (juices fortified with inulin, L-carnitine, vitamins, calcium and magnesium) [60]. 
Also functional liquid dairy products, including yogurts, are among the most succeeding products. These 
foods are usually enriched with pre- and/or probiotics in order to impart some beneficial functions in the 
body. This type of dairy products features an impressive growth of many millions of dollars throughout 
EU. In this area the most representative brands are Danone® and Unilever®, which have faced an 
exponential growth [22]. A widely known product is Benecol® a dairy beverage enriched with camelina 
oil as a source of fatty acids, in particular of the omega-3 type associated with cholesterol lowering. 
Functional butters are another example of products with great market expansion. Becel® pro activ, trade 
name owned by Becel® (Unilever®), is a well-known product to lower cholesterol, property related with 
the added plant stanol esters [61]. 
Several companies recognized worldwide, betting much of their investment in products referred as 
"healthier". Food companies such as Nestlé®, Danone® Group, Kraft Foods®, Unilever®, PepsiCo®, Coca-
Cola®, and Heinz® are some of these examples. Recently, there has been also the promotion of some 
joint-ventures between food industries and pharmaceutical companies, because the cost and time of 
producing functional foods is lower than producing pharmaceutical products.22 
Among all the functional food markets, the major product launches are: milk products, confectionery, 
bakery and baby foods.19,40 The market of functional dairy products has grown rapidly due to the 
recognized large investment in research directed to the sector, which assured the development of new 
marketable products. Furthermore, many authors explain the great success of functional dairy products 
due to the good image consumers have of them [22,62].  
 
 
3. PHENOLIC COMPOUNDS AS BIOACTIVE INGREDIENTS  
 
3.1. Chemical and biological issues 
The PC are secondary metabolites of plants generally involved in the defense against ultraviolet 
radiation or aggression by pathogens [63], being the major antioxidants of our diet [64]. 
Their main dietary sources are fruits and plant-derived beverages such as fruit juices, tea, coffee 
and red wine. Vegetables, cereals, chocolate, and dry leguminous also contribute to the total PC intake 
[65,66]. The total dietary intake is about 1g/day, being much higher than that of all other known dietary 
antioxidants, about 10 fold higher than that of vitamin C and 100 fold higher than those of vitamin E and 
carotenoids [64,67].  
In nature, PC are usually found conjugated to sugars and organic acids [66,68]. They can be 
classified according to two major types, flavonoids and non-flavonoids (Figure 2) and in different classes, 
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which depend on the number of phenol rings and on the structural elements linking these rings [68,69]. 
Nevertheless, there is still some controversy in associated to the classes of PC to be considered [70]. 
Flavonoid group, shares a common structural feature, consisting of 2 aromatic rings (A and B) 
bounded together by 3 carbon atoms that form an oxygenated heterocycle (ring C). It can be divided into 
six subclasses according to the type of involved heterocycle: flavonols, flavones, flavanols, flavanones, 
isoflavones and anthocyanins [69]. The individual differences within each group refer to variations in the 
number and arrangement of the hydroxyl groups, as well as in their extent of alkylation and/or 
glycosylation [66]. Among the various compounds, quercetin and catechins stand out as the most 
common ones.  
Several studies have suggested that flavanols, flavones, and flavanones, the main flavonoids found 
in citrus fruits, occur at high concentration in the cocoa-rich products and dark chocolates, and are related 
to the reduction of cardiovascular disease risk [71,72].  
The non-flavonoids group is composed byphenolic acids, stilbenes and lignans [69]. Phenolic acids 
are found abundantly in foods and can be divided into two classes: hydroxybenzoic and hydroxycinnamic 
acids. The hydroxybenzoic acid content in edible plants is generally low, with the exception of certain red 
fruits and onions. Normally these fruits have large amounts of gallic acid. The hydroxycinnamic acids are 
more common than hydroxybenzoic acids and consist mainly of coumaric, caffeic, ferulic and rosmarinic 
acids [66,69]. Stilbenes are not typically ingested in large quantities since plants only synthesized them if 
subjected to episodes of infection or injury. However, grapes and wine contain significant amounts of 
resveratrol, making this stilbene one of the most studied ones [56]. Lignans, such as secoisolariciresinol, 
are considered to be phytoestrogens. Its richest dietary source is linseed, which contains 
secoisolariciresinol and low quantities of matairesinol [59]. 
Several studies have reported the antioxidant potential of certain PC being apigenin, quercetin, 
kaempferol, myricetin, luteolin, isorhamnetin, caffeic and p-coumaric acids the most cited (Table 1) 
[73,74]. Yeh & Yen [75] demonstrated that administration of phenolic acids, mainly gallic acid, in rats 
induces phase II hepatic phenol sulfotransferases (PSTs) and increase plasma antioxidant capacity. 
Another study administrated an anthocyanin rich extract, obtained from the cones of Abies koreana 
E.H.Wilson, to male rats and proved that it increased plasma antioxidant capacity [76]. Flavan-3-ols, 
mostly catechins, were detected in high amounts in rat blood, and were able to suppress the occurrence of 
gastric lesions in rats [77]. These compounds showed high antioxidant activity leading to a great 
protection of endothelial cells from oxidative injury [78]. Several studies were conducted to prove the 
antioxidant properties of flavones. The apigenin revealed strongly antioxidant activity in vitro and in vivo 
assays through neuroprotective effects against oxidative stress [79,80]. Another flavone, kaempferol, also 
revealed high antioxidant activity, being recommended as a good natural antioxidant due to its tendency 
to donate electrons and, therefore, stabilizing food products [81]. 
The most studied PC in terms of antifungal properties are phenolic acids, flavonoids and stilbenes 
[6] presented in Table 2. The antimicrobial activity of phenolic acids was reported by various authors 
which proved that clorogenic, ferulic and gallic acids have the ability to inhibit the growth of different 
microorganisms such as Staphylococcus aureus and S. epidermis, Escherichia coli, Pseudomonas 
aeruginosa and Listeria monocytogenes [82-87]. The catechin, belonging to flavan-3-ols group, inhibited 
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the growth of various fungi and bacteria strains, such as Candida albicans [88], Helicobacter pylori [86] 
and Escherichia coli [87]. Also the flavanones, hespertin and narigenin, showed strong antifungal and 
antibacterial effects against S. aureus, C. albicans and Lactococcus lactis [89-91]. Strong activity against 
P. aeruginosa, Salmonella typhimurium, S. epidermis, Bacillus subtilis and Saccharomyces cerevisiae 
was displayed by two examples of flavones, apigenin and luteolin [92,93]. Studies with flavonols 
(kaempferol and rutin) revealed their antibacterial activity against Enterococcus faecalis and S. aereus 
[94,95]. The antibacterial activity of genistein, an isoflavone, was studied against Vibrio harveyi [96], 
Bacillus anthracis [97], Klebsiella pneumonia and Salmonella typhi [98]. Finally, resveratrol, a stilbene, 
showed antibacterial activity against various bacteria such as E. faecalis [94], Campylobacter spp., 
Arcobacter butzleri [99], S. cerevisiae, Aspergillus ninger, Penicillum expansum [100]  and H. pylori 
[101], as also against C. albicans fungi [102]. 
Other studies demonstrated that PC possess anti-inflammatory activity (Table 3). Wang et al [103] 
reported the anti-inflammatory activity of hesperetin, a flavanone, and suggested that this PC was 
inhibitor of tumor necrosis factor α and interleukin-6 in mouse macrophages. This activity was also 
verified by different authors for two important flavones, apigenin and luteolin. Funakoshi-Tago et al 
[104] demonstrated that apigenin effectively inhibited carrageenan-induced inflammation in murine 
model through inhibition NF-κB transcriptional activation mechanism. Luteolin was described as having 
the ability to inhibit tumor necrosis factor α and NF-kB transcriptional activation under in vivo assays 
[104,105], to reduce nitric oxide synthase expression in vitro [106] and significantly alleviated 
neurological deficit in vivo suppressed edema after ischemic stroke due the decreased expression of 
several molecules involved in inflammatory processes [107]. The potent anti-inflammatory effect of 
luteolin was also described, by interfering essentially in the heat shock protein 90 (Hsp90) secretion 
[108].  
Table 4 represents some PC with proved antitumoral activity. Some authors have shown an 
inhibition of reductase activity in tumor cells by treating leukemic cell lines with gallic acid [109]. 
Another study also demonstrated the efficiency of this acid against glioma cell lines, by decreasing cell 
viability, proliferation and angiogenesis [110]. Other authors reported that by inducing apoptosis and 
activating caspases, the gallic acid also had efficient effects on lung cancer cell lines. In a study with 
murine models it was demonstrated the same capability of reducing tumor growth [111]. Some authors 
demonstrated the anticancer effect of the anthocyanidins, cyaniding and delphinidin, against colorectal 
carcinoma [112]. In particular, delphinidin inhibited cell growth and decreased tumor size [113]. In vivo 
assays revealed that catechin, a flavan-3-ol, inhibited tumor formation and increased the life span of the 
animals. In turn, in vitro tests have confirmed that this compound inhibited the migration of melanoma 
cells [114]. In a study conducted by Alshatwi [115] catechins proved to exhibit anticancer effects and 
induce apoptosis on the MCF-7 cancer cell line (breast cancer) without significant toxicity. Within the 
flavanone group, hespertin could inhibit the cell growth and induce apoptosis resulting on inhibition of 
human mammary carcinoma cell lines [116]. Alshatwi et al [117] revealed that hespertin exhibited in 
vitro anticancer activity against human cervical cancer cell lines through the reduction of cell viability 
and induction of apoptosis. Narigenin proved anti-proliferative and apoptotic effects trough 3-(4,5-
dimethylthia-zol-2-yl)-2,5-diphenyltetrazolium brumide (MTT) assay in skin carcinoma cells line (A431) 
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by inducing ROS generation and cell cycle arrest [118]. In flavone group, apigenin and luteolin are the 
most studied PC. The apigenin showed anti-mutagenic and apoptotic effects in human lymphoma cells 
line [119] and inhibited pancreatic cancer cell growth and migration [120]. On the other hand, luteolin 
exhibited pro-apoptotic activities in colorectal cancer cells [121] and demonstrated anticancer effect on 
human lung carcinoma cell line (NCI-H460) through Sirt1-mediated apoptosis and the inhibition of cell 
migration [122]. The luteolin also could synergize the antitumor effects of 5-fluorouracil on HepG2 and 
Bel7402 cells, which might be related with apoptosis and regulation of 5-fluorouracil metabolism [123]. 
Moreover, Chian et al [124] demonstrated in vivo that luteolin inhibited nuclear factor (erythroid-derived 
2)-like 2 (Nrf2) in mouse liver and significantly enhanced the therapeutic effect of cisplatin both in 
animal and in cell lines. The luteolin was able to significantly inhibit cellular growth, cell migration, and 
induce S and G2/M cell cycle arrest and apoptotic cell death in gioblastoma multiforme (GBM 8401) 
cells [125], and to attenuate the growth of estrogen receptor in human breast cancer cells (MDA-MB-231) 
both in vitro and in vivo assays suppressing the proliferation of breast cancer cells in mouse model [126]. 
Additionally, Yang et al [127] combined luteolin and paclitaxel, which led to an enhancement of 
apoptosis in human breast cancer cells (MDA-MB-231) and to a decrease in orthotropic tumor growth in 
nude mice. Quercetin and kaempferol are the two most studied flavonols and were investigated in various 
human and murine cell lines by different authors, with effective results against cells of different 
carcinoma [128-134]. The effects of genistein, an isoflavonoid, in prostate carcinoma were assessed by 
using in vitro assays with human cell lines [135] and in vivo models using murine [136]. The results of 
these studies indicated that genistein was capable to inhibit cell proliferation as well as to upregulate 
glutathione peroxidase and downregulate apoptosis inhibitor agents. In stilbene group, resveratrol 
represent the most important PC. This compound presented a direct antitumor activity against many 
carcinoma types including leukemia, neuroblastoma, pancreatic, breast, prostate and renal carcinoma 
[137,138]. 
The hepatoprotective effects of same PC isolated from natural sources are presented in Table 5. 
Phenolic acids, namely caffeic, chlorogenic and gallic acids, showed hepatoprotective effects through 
different mechanisms [139-142]. Within flavanones group, hespertin and naringenin emerge with 
hepatoprotective properties. The hespertin is responsible for combating against CCL4 (carbon 
tetrachloride)-induced hepatic damage in mice through decrease of various enzymes [143]. The 
naringenin showed hypoglycemic, vasorelaxant and hepatoprotective properties through decrease of the 
enzymes involved in liver diseases [144]. Regarding the flavone group, apigenin and luteolin play an 
important role in hepatoprotective effects. Various authors described this PC as displaying hepatic 
properties including the decrease of different enzymes harmful to the liver cells as well as ability to 
inhibit HepG2 cell line (liver carcinoma) [139,145,146]. Isorhamnetin, kaempferol, myricetin and 
quercetin are some examples of flavonols implicated in hepatoprotective effects. These compounds were 
able to reduce damaging enzymes such as aspartate transaminase (AST) and alanine transaminase (ALT) 
[142,143,147]. Additionally, Pereira et al [139] described kaempferol as hepatoprotective agent via 
reducing the growth of HepG2 cell line.  
 
3.2. In vitro versus in vivo performance 
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Several studies conducted in vitro were designed to evaluate the bioactivity of phenolic 
compounds extracted from different plants. Despite the scientific relevance of these studies, biochemical, 
physiological or metabolic parameters are not considered [2,3,148]. Thus, there has been an exponential 
increase in the number of in vivo studies using rats, mice and rabbits; however, studies involving humans 
are still very scarce [149]. Unfortunately, there is a large number of studies on the in vitro properties of 
different natural matrices that did not advance to in vivo studies. But, after metabolism, the various 
compounds can be converted to their active forms or otherwise inactivated or attached to biomolecules, 
which can modify its original purpose [148]. These effects are not considered on the in vitro assays and, 
therefore, in vivo validation is always required [3]. 
In spite of recent scientific advances, the bioavailability of PC is not clearly defined since, during 
ingestion, digestion and absorption these molecules can undergo various biochemical reactions [6, 150]. 
Therefore, the in vivo effect of PC cannot simply be extrapolated from the in vitro activities. For example, 
the antioxidant activity of a particular food verified in vitro differs when tested in vivo [151]. Otherwise, 
some phenolic complexes have low antioxidant activity when studied in vitro, but in vivo may undergo 
metabolic transformation into simpler compounds, which leads to an increase in plasma antioxidant 
capacity [152]. 
Reviewing Figure 3 it is possible to verify that although the in vivo and in vitro studies with PC 
have started in 1960, the highest impact has been observed since 1990 for in vitro studies, and five years 
later for in vivo assays. Despite the exponential increased number of studies, in vitro experiments are 
always higher than in vivo studies. In contrast there is a higher number of patents for in vivo than in vitro 
assays suggesting a growing interest from the industry towards these outputs. 
 
3.3. Bioavailability of phenolic compounds as a main factor in bioactivity 
The large amounts of PC consumption through feed is not directly related to improved 
bioavailability profile [153]. The health benefits from natural PC depend on their absorption and 
metabolism [154]. 
In vitro evaluation systems to determine the bioactive potential of PC are based on the surface of 
organs such as the inner wall of the gastrointestinal tract, but such systems cannot reflect antioxidant in 
vivo effects [77] because the physico-chemical characteristics (molecular size, base structure, degree of 
polymerization and/or glycosylation, solubility, interaction with other compounds) are major factors 
limiting the PC action [153].  
The bioavailability is considered a fundamental step to guarantee the bioefficacy of PC, i.e., at 
nutritional level, the bioavailability is the fraction of a given food that the organism can utilize, and is 
therefore a matter of nutritional efficacy [155]. So, the bioavailability of the PC can be affected by 
various factors that may interfere directly in bioavailability or decreasing the PC amounts in food. 
External factors, food processing, interaction with other compounds and intestinal factors are some 
examples of those factors [156]. The bioavailability depends on different and complex processes such as 
liberation, absorption, distribution, metabolism and elimination phases [155], however, the absorption at 
intestinal level is considered the limiting factor contributing to the bioavailability decrease. Permeability, 
lipophilicity, uptake and efflux by transporters are some factors that affect the amounts of each compound 
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which is absorbed by the mesenteric architecture and sent to the liver tissues through intestinal cells 
[157].  
Phenolic compounds with small-molecular weight, for example, gallic acid and isoflavones are 
easily absorbed through the gastrointestinal tract [153]. On the contrary, the majority of PC are relatively 
poorly absorbed (absorption rates between 0.3 and 43%) and the circulation in plasma concentrations of 
their metabolites can be low [155]. For instance, in flavonols group, the quercetin and kaempferol 
demonstrated various biological in vitro effects [158]. Nevertheless, the use of these flavonols as a health 
promoting compound has been limited due its poor bioavailability caused by low water solubility, poorly 
absorption rate and high instability in neutral and alkaline media including different organs such as small 
intestine, colon, liver and kidney [157,159]. Additionally, in flavones group, the use of apigenin is also 
very limited because of its instability and poor solubility in the pure form [160].  
 
4. PHENOLIC COMPOUNDS IN FUNCTIONAL FOODS AND NUTRACEUTICALS 
 
4.1. Health claims 
The health claims of food or its constituents are an essential tool when it comes to marketing, that 
is, consumers are more likely to consume foods when they are sold as “healthy food”. However, 
regulatory identities are necessary to avoid false claims and deception of consumers [161]. There is a 
large and growing number of studies conducted in order to characterize the bioactivities of different PC 
with the aim to introduce them in food and add value to foodstuffs. Despite all the interesting results 
previously mentioned, PC application in food industry has to overcome various laws and rules. In 
European Union, the utilization of health claims was regulated in 2006 by EFSA. The health claims 
suggest or imply the relationship between the food or its constituents with health [161].  
The regulations of the European Commission are quite restrictive in their use and applicability. 
Despite the wide variety of PC with promising bioactivities, the only ones authorized with health claims 
in the Regulation (EU) No 432/2012 are phenolic olive oil. Still, the conditions of the use of this health 
claim are limited to a minimum concentration of hydroxytyrosol in a certain amount of olive oil (5 mg of 
hydroxytyrosol in 20 g of olive oil). In these conditions, it is possible to claim that olive oil PC contribute 
to the protection of blood lipids from oxidative stress [162]. 
 
4.2. Presence in foods with reported bioactivity  
PC are currently receiving high attention because of their beneficial health effects, mainly 
antioxidant [163,164], anti-inflammatory [165,166], antimicrobial [167], cardio-protective [168], cancer-
preventive [16] and neuro-protective [169] properties. These compounds assume different forms in the 
body allowing prevention or treatment of these diseases [170-173]. Therefore, several studies indicate that 
an increase in the consumption of foods rich in PC can be associated with the prevention of the mentioned 
diseases [64,168,171,174]. 
Table 6 includes examples of some foods rich in PC with the respective reported biological effects 
associated to their antioxidant activity (prevention of cardiovascular disease and cancer). 
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The wine, particularly, red wine, is an important source of flavonoids, especially catechins and 
procyanidins that proved to have a significant protective effect against coronary heart disease (CHD) 
[175,176]. A correlation was also noticed between increasing levels of flavonoids ingestion from fruit and 
vegetables and the reduction in CHD [177,178]. Catechins and procyanidins have shown, in vitro, to be 
powerful inhibitors of LDL (Low Density Lipoprotein) oxidation, higher than, for example, α-tocopherol 
[179]. Moreover, it was described that the moderate consumption of wine by humans leads to an increase 
in the antioxidant capacity of plasma [180]. Other studies have been carried out on the antioxidant activity 
– through inhibition of copper-catalysed oxidation of human LDL – of a selection of Californian wines. 
The relative inhibition of LDL oxidation (calculated with respect to the total phenol concentration of each 
sample) varied from 46% to 100% for red wines, and from 3% to 6% for white wines [181]. 
The quercetin, flavonol also presented in the wine, when ingested in large quantities reduces the 
incidence of lung cancer [182] and ischemic heart disease [176]. Teissedre & Landrault [175] studied the 
in vivo effect of gallic acid (originated from red wine) in rats, noticing a reducing mortality rate from 
CHD. Catechins present in green tea affect lipid metabolism by different pathways and prevent the 
appearance of atherosclerotic plaque. Its intake decreases the absorption of triglycerides and cholesterol 
and these findings are in accordance with the fact that it increases fat excretion [183]. Green tea, due to its 
components, is also appointed to assist in Alzheimer´s disease prevention [184]. 
Sesso, Gaziano, Buring & Hennekens [185] studied the relationship between tea and coffee 
consumption and myocardial infarction; in this study it was verified a 44% reduction of the 
cardiovascular risk in the individuals drinking more than one cup of tea per day. For the coffee, 
significant correlation was achieved. All absorbed catechins, procyanidins and metabolites can contribute 
to increased antioxidant capacity of plasma. Their cardioprotective effects stem from the ability to inhibit 
lipid peroxidation, chelate redox-active metals and attenuate other processes involving ROS [176]. 
The major dietary sources of stilbenes include grapes, wine, soy, peanuts, and peanut products 
[186]. Stilbenes, namely resveratrol, have shown effects in preventing or treating certain diseases such as 
breast cancer [187,188] and skin tumors [189]. The resveratrol has been shown to inhibit ribonucleotide 
reductase and other cellular events associated with initiation, promotion and progression of 
carcinogenesis [189]. The orange juice and grapefruit juice contain high amounts of hesperretin and 
naringenin and exhibit anti-carcinogenic effects [190]. Tan et al [129] also studied the antiangiogenic 
potential of quercetin, which demonstrated to inhibited several important steps of angiogenesis including 
proliferation, migration and tube formation of human microvascular dermal endothelial cells. Another 
study reported the synergistic effect of grape components in the prevention of diabetes and cardiovascular 
diseases, and in the promotion of oral health [184]. 
The biological activities of PC in the human body are mostly attributed to the ability of these 
compounds to exert antioxidant actions. The main antioxidant activity of the polyphenols consist in 
potentiate cell detoxification systems, such as the superoxide dismutase, catalase or glutathione 
peroxidase systems, and inhibit ROS generating enzymes, such as xanthine oxidase and NADPH oxidase 
(Nicotinamide Adenine Dinucleotide Phosphate-Oxidase) [168]. However, recent studies suggest that the 
mechanisms by which PC exert their protective action against cardiovascular diseases and cancer, are not 
simply due to their redox properties, but due to the ability to bind directly to proteins [191]. Such a mode 
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of action would induce the inhibition of key enzymes, the modulation of cell receptors or transcription 
factors, as well as the perturbation of protein aggregates, which can regulate cell functions related to, e.g. 
growth and proliferation, inflammation, apoptosis, angiogenesis, metastasis, and immune responses, in 
various ways by affecting signal transduction pathways [168,192-194]. However, there is a great diversity 
of PC, and the way in which they interact with the proteins depends on the physical chemical properties 
of both [191]. 
Summarizing, PC can be considered as good candidates for the prevention and treatment of several 
diseases. Ongoing studies are particularly devoted to understand all action mechanisms in the body, 
including bioavailability features. 
 
4.3. Applications in functional foods and nutraceutical formulations 
Nowadays, some functional foods and nutraceuticals capturing consumer’s interest can be found 
commercially. The scientific community was able to prove the health beneficial effects of this type of 
products, which the food and pharmaceutical industries have emulated, making viable the production of 
some novel and original products of high income. The medicinal and aromatic plants play an important 
role in this area due to their antioxidant, antimicrobial and other beneficial effects in combating certain 
diseases. 
Figure 4 schematizes possible PC intake processes through fortified foods and their effects in the 
human body. The incorporation of these compounds in food can be performed directly in its free form; 
however, microencapsulation technique emerged as a very effective and promising strategy to assure 
bioavailability of these compounds, helping to surpass problems of food processing and ingestion [195]. 
After ingestion the compounds are absorbed into the bloodstream causing changes in various cellular 
mechanisms, leading to prevention of various diseases. 
There are many articles in the literature that demonstrate the bioactivity of various plants and fruits 
PC’s, studies reporting its application in functional foods or nutraceutical formulations development, is 
still scarce. Table 7 lists some examples of PC used as nutraceuticals or bioactive compounds in 
functional foods. Isoflavones of soy were used in dietary supplements to control the menopausal 
symptoms, while anthocyanins of cranberry were used in nutraceutical capsules for antioxidant purposes. 
Moreover examples of case studies with incorporation of phenolic extracts into food matrices are also 
provided in Table 7. Phenolic extracts of pomegranate fruits were incorporated by Robert et al [196] and 
Pillai et al [197] in yogurt and pasta, respectively, to enhance antioxidant activity. The phenolic extracts 
of pomegranate were also incorporated by Çam et al [198] into ice cream aiming at enhancing the 
antioxidant and α-glucosidase inhibitory activities. Ezhilarasai et al [199] and Pasrija et al [200] 
incorporated garcinia and green tea phenolic extracts, respectively, in bread resulting in a new product 
with increased antioxidant activity. Chouchouli et al [201] and Martins et al [202] used grape seed and 
blackberry flowers, respectively, to add value and antioxidant activity to functional yogurts. The 
incorporation of Veronica phenolic extracts caused an increase in the antibacterial activity of a new cream 
cheese [203]. More recently, Caleja et al [54,55], incorporated phenolic extracts in cottage cheese using 
fennel and chamomile extracts, reporting a higher antioxidant activity and an extending shelf-life in 
comparison with the control cottage cheese without extracts. Also in cottage cheese, the same research 
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group incorporated mushroom [204] and rosemary extracts [205] to improve antioxidant properties. 
Fennel and chamomile extracts were also incorporated in yogurts and showed best results when compared 
with control and yogurts with a synthetic additive (potassium sorbate – E202) [206].Another recent study 
described the incorporation of PC of guava flower in bread melanoidins, which retained its quality while 
adding antioxidant value [207].  Finnaly, Miceli et al [208] showed that the incorporation of borage in 
fresh pasta introduced antimicrobial properties. 
 
4.4. Present market and future tendency 
The Compal company (Sumol+Compal, S.A.) has developed products defined as functional and 
marketed in the form of nectar, as is the case of Compal Vital AntiOx®, ensuring antioxidant properties 
due to the presence of a selected range of red fruits (http://www.compal.pt/#/pomar/nectares/vital/). 
Guimarães et al [209] proved that the red fruits are rich in phenolics providing antioxidant activity. 
However, when added to food, the PC are not present in its pure form, they are added mainly as rich 
extracts or fruits pulps. 
In the field of nutraceuticals and dietary supplements, it is also observed a growing interest 
enforced by the increase of published works on the topic. In literature, it is common to find the 
description of product formulations incorporating PC, but through the use of natural extracts typically 
used to fortify foods. These products have been commonly launched on the market, in the form of tablets 
or syrups, claiming health benefits due to the presence of PC [210]. 
Magiera et al [211] reported the presence of fourteen flavonoids in a dietary supplement (not 
specified), relating them with the shown antioxidant capacity. In another study, performed by Pereira et 
al. [212], the phenolic profile of different formulations of dietary supplements (infusions, syrups and 
tablets) based on Cochlospermum angolensis Welw, also known as borututu, used for the treatment and 
prevention of liver diseases, was described. The amount of PC was also related with the observed 
antimicrobial activity of the supplements. A similar study was conducted by Bresciani et al [213] in 
which the authors performed the phenolic characterization of three herbal supplements, through 
identification by MSn-UHPLC. 
Even the development of functional foods and nutraceuticals is considered a fast process, these 
products often require sound scientific evidence before being introduced in the market. Clinical studies 
are generally very expensive and thus not affordable for most of the companies dealing with the 
manufacture this type of food products, which cannot bear the expenses to carry out all tests [51,184,214]. 
For each clinical study, research companies and/or universities need to combine hundreds to thousands of 
subjects. On average each of these studies can cost several thousands of dollars [41]. 
Despite the fact that laws related to this type of products are quite different among countries, the 
labeling rules are similar. It is through labeling that consumers have access to all information concerning 
food composition and respective health benefits, which in the case of functional foods and nutraceuticals 
becomes very important [184]. Some studies indicate that women are more influenced to buy new 
products [215], partly because they are more concerned with health issues [39] but also since they are 
generally in charge of home shopping.  
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The main factors influencing functional foods purchasing are: lifestyle, health awareness, taste for 
healthier foods [216] and packaging design. So, it is important that consumers have knowledge and 
familiarity with functional foods [39], product safety [39,217] and information concerning the base 
product (food matrix) [39,218]. Moreover, legislation changes in the EU panorama in what concerns new 
products has also helped consumer attitude modification. In that context a greater reliance on the 
information passed by the labels and advertising regarding nutritional and health virtues of these food 
products is evident [39].  
In general, the functional products still need to overcome some obstacles to ensure success in the 
market and win consumer confidence. Therefore, to support the high demand for functional foods it is 
necessary to combine efforts of various areas such as science, industry, market, media, education and 
governmental policies, and thus manage to develop a reputable product image. The product promotion 
should be perceived by all age groups, from the youngest to the elderly, and thus must be carried out 
simply and clearly with accessible vocabulary [184,219]. However, the success the functional foods also 
depends on the organoleptic attributes, especially flavor, appearance, price and health claims [31]. 
Therefore, the food industry has to take into consideration some factors for the development/restructuring 
of functional foods, highlighting: sensory acceptance, price, stability, chemical and functional properties 
[41,220]. 
Technological development also allows greater innovation in food products. According with 
Betoret et al [41], the technologies applied to foods can be divided into three groups. The first group is 
formed by traditional technologies in food processing. The second group encompasses techniques used to 
protect biologically active compounds, such as microencapsulation, and the development of edible films, 
coatings and vacuum impregnation. The third group is made up of the latest technologies that can be 
applied to develop customized functional products. 
PC derived from natural sources are known to exhibit various bioactivities [168], and thus their 
introduction into food matrices will provide a higher intake. However, the PC can exhibit several 
instabilities when introduced in foods, arising either from food processing (manufacturing temperatures) 
or long storage periods in contact with the food matrix, among other factors [41,195]. Thus, technologies 
progress has introduced advances in the food industry, enabling innovation into food products 
development. In this context, microencapsulation is one of most frequently applied methods to overcome 
problems related to PC instability and assure controlled release in foods [221,222].  
Microencapsulation is emerging as a technique capable of protecting bioactive compounds, such as 
phenolics, by means of a protective material (e.g. natural polymer or waxes). Some authors state that with 
this technique it is possible to protect compounds from adverse conditions such as light, oxidation, 
hydrolysis and moisture contact, thereby ensuring functionality maintenance and thus bioavailability 
[195,223-225]. When the bioactive is added to the food matrix in the form of microparticles it is possible 
to minimize problems related to food storage time (reduce compounds degradation) and prevent 
deleterious interactions with the food matrix [41,202]. However, it is desired that the introduced 




Throughout of this review, the biological effects of polyphenols, their action when incorporated into a 
foodstuff or nutraceutical formulation, as well as their relevance to human health were evidenced. It was 
shown how PC consumption provides significant protection against disease development and progression, 
including in cardiovascular and cancer diseases. Despite the existing literature evidences reporting that 
polyphenols represent a great hope in the prevention of many chronic human diseases, there are still in 
our opinion fields to explore, particularly in what concerns the elucidation of some action mechanisms. 
The demand for functional foods in EU varies considerably from country to country due mainly to 
tradition and cultural heritages. In terms of marketing, functional foods must be promoted in a clear and 
objective manner so they can be easily recognized by final consumers. The market should promote clearly 
the product avoiding excessive scientific vocabulary. The labels should contain a specific logo for these 
foods ensuring an easy recognition and differentiation from other products. 
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Table 1. Examples of phenolic compounds with antioxidant activity. 





Gallic acid Increase of P-Form PST activity In vivo 
(rats) 
[75] 
Anthocyanins Cyanidin; Delphinidin; 
Malvidin; Petunidin 
Donation of electrons or hydrogen 





Flavan-3-ols Catechin DPPH radical scavenging activity 






Superoxide radical scavenging 
activity and reducing power 
In vitro [78] 
Flavones Apigenin Reduction of intracellular reactive 
oxygen species   
In vitro [79] 
DPPH radical, superoxide radical 
and hydroxyl radical scavenging 
activity 
Stimulation of antioxidant enzymes 
to provide additional protection for 





Kaempferol DPPH radical scavenging activity, 
reducing power and lipid 
peroxidation inhibition  
In vitro [81] 
DPPH - 2,2-diphenyl-1-picrylhydrazyl; PST – phase II hepatic phenol sulfotransferases 
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Table 2. Examples of phenolic compounds with antimicrobial activity.  





Staphylococcus aureus, Staphylococcus 
epidermidis, Escherichia coli, Candida albicans, 
and tropicalis (antiwound infection, repair and 
contraction) 
In vitro  
In vivo (rodent)  
[82] 
Ferulic acid Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus, and Listeria 
monocytogenes 
In vitro [83] 
Gallic acid Escherichia coli, Salmonella typhi, Vibrio 
cholera, Enterococcus faecalis, Staphylococcus 
aureus, Staphylococcus epidermidis; 
Microsporum gypseum, Trichophypon rubrum 
In vitro [84] 
Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus, and Listeria 
monocytogenes 
In vitro [83] 
Campylobacter coli, Campylobacter jejuni In vitro [84] 
Helicobacter pylori In vitro [85] 
Escherichia coli In vitro [86] 
Flavan-3-
ols 
Catechin Candida albicans In vitro [88] 
Helicobacter pylori In vitro [86] 
Escherichia coli In vitro [87] 
Flavanones Hespertin Staphylococcus aureus; Candida albicans In vitro [89] 
Naringenin Lactococcus lactis In vitro [90] 
Staphylococcus aureus In vitro  
In vivo (mice) 
[91] 
Flavones Apigenin Pseudomonas aeruginosa, Salmonella 
typhimurium, Proteus mirabilis, Klebsiella 
pneumoniae and Enterobacter aerogenes 
In vitro [92] 
Staphylococcus epidermis, Bacillus subtili, 
Saccharomyses cerevisiae 
In vitro [93] 
Luteolin Staphylococcus epidermis, Bacillus subtili, 
Saccharomyses cerevisiae 
In vitro [93] 
Flavonols Keampferol Enterococcus faecalis In vitro [94] 
Rutin Acinetobacter baumannii, Staphylococcus aureus, 
Enterococcus faecalis, Bacillus subtilis. 
In vitro [95] 
Isoflavones Genistein Vibrio harveyi In vitro [96] 
Bacillus anthracis In vitro [97] 
Klebsiella pneumonia, Salmonella typhi In vitro [98] 
Stilbenes Resveratrol Enterococcus faecalis In vitro [94] 
Candida albican In vitro [102] 
Campylobacter spp, Arcobacter butzleri In vitro [99] 
Saccharomyces. cerevisiae; Aspergillus ninger, 
Penicillum. expansum 
In vitro [100] 
Helicobacter pylori In vitro [101] 
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Table 3. Examples of phenolic compounds with anti-inflammatory activity.  
Phenolic compound Effect Type of assay Reference 
Flavanone Hesperetin Inhibition of  tumor necrosis factor α and 
interleukin-6 in mouse macrophages 
In vitro  [103] 
Flavones Apigenin Inhibition of  NF-κB transcriptional 
activation 
In vivo (mice) [104] 
Luteolin Inhibition of  TNF-α In vivo (mice) [105] 
Inhibition of  NF-κB transcriptional 
activation 
In vivo (mice) [104] 
Reduction of nitric oxide synthase 
expression  
In vitro [106] 
Downregulation of TLR4, TLR5, NF-κB, p-
p38MAPK 
In vivo (rats) [107] 
Prevention of the activity of Hsp90 In vitro  
In vivo (mice) 
[108] 
NF- κB – factor nuclear kappa B; TNF-α - tumor necrosis factor α; TLR4 – toll-like receptor 4;TLR5 - 
toll-like receptor 5;  p-p38MAPK – phosphor-p38 MAPK; Hsp90 – heat shock protein 90. 
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Table 4. Examples of phenolic compounds with antitumoral effects. 
Phenolic compound Type of tumor Type of assay Reference 
Phenolic 
acids 
Gallic acid Leukemia In vitro (human cell lines) [109] 
Glioma In vitro (human cell lines) 
In vitro (murine cell lines) 
[110] 
Lung carcinoma In vitro (human cell lines) 
In vitro (murine cell lines) 
[111] 
Anthocyanins Cyanidin Colorectal carcinoma In vitro (human cell lines) [112] 
Delphinidin Prostate carcinoma In vitro (human cell lines) 
In vitro (murine cell lines) 
[113] 
Colorectal carcinoma In vitro (human cell lines) [112] 
Flavan-3-ols Catechin Breast cancer (MCF-7) In vitro (human cell lines) [115] 
Melanoma In vitro (human cell lines) 
In vitro (murine cell lines) 
[114] 
Flavanones Hespertin Breast carcinoma In vitro (human cell lines) [116] 
Cervical carcinoma In vitro (human cell lines) [117] 
Naringenin Skin carcinoma In vitro (human cell lines) [118] 
Flavones Apigenin Lymphoma  In vitro (human cell lines) [119] 
Pancreatic cancer  In vitro (human cell lines) [120] 
Luteolin Colon carcinoma In vitro (human cell lines) [121] 
Non-small cell lung cancer In vitro (human cell lines) [122] 
Hepatocellular carcinoma 
(HepG2 and Bel7402) 
In vitro (human cell lines) [123] 
Non-small cell lung cancer In vivo (mouse cell lines) [124] 
Breast cancer (MDA-MB-
231)  
In vitro (human cell lines) [127] 
Glioblastoma (GBM 8401) In vitro (human cell lines) [125] 
Breast cancer (MDA-MB-
231)  
In vitro (human cell lines) 
In vitro (mouse cell lines) 
[126] 
Flavonols Kaempferol Hepatocarcinoma 
Pancreatic carcinoma 
In vitro (human cell lines) [131,132] 
Breast cancer (MCF-7) In vitro (human cell lines) 
In vivo (female mice) 
[134] 
Ovarian cancer  In vitro (human cell lines) [133] 





In vitro (human cell lines) [128-130] 
Isoflavones Genistein Prostate carcinoma In vitro (human cell lines) 
In vivo (murine models) 
[135,136] 










Table 5. Examples of phenolic compounds with hepatoprotective effects. 
Phenolic compound Effect Type of assay Reference 
Phenolic 
acids 





↓ HBV DNA replication In vitro [141] 
Gallic acid ↓AST, ↓ALT, ↓TB, ↓GGT In vivo (rats) [142] 
↑SOD, ↑CAT,↑GSH, ↑lipase, ↑%-amylase, 
↑Alb,↓ALP, ↓AST, ↓ALT, ↓triacylglycerol, 
↓TB, ↓glucose, ↓cholesterol  
In vivo (rats) [140] 
Flavanones Hespertin ↓AST, ↓ALT, ↓MDA, ↑SOD, ↑GSH-Px In vivo (mice) [143] 
Narigenin  ↓PGT, ↓ALP, ↑&-GTP In vivo (rats) [144] 
Flavones Apigenin ↓SGOT, ↓SGPT, ↓ALP, ↓TG, ↓TC, ↓LDL, 
↓BUN, ↓creatinine, ↓TB, ↑HDL 
In vivo  (wistar 
rats) 
[146] 
GI50 = 52.06 µg/mL  In vitro (HepG2 
cells) 
 [139] 
Luteolin ↓SGOT, ↓SGPT, ↓ALP, ↓TG, ↓TC, ↓LDL, 
↓BUN, ↓creatinine, ↓TB, ↑HDL 
In vivo (wistar 
rats) 
[146] 
GI50 = 85.8 and 20.2 µM  In vitro (Hep G2 
cells) 
[145] 
Flavonols Isorhamnetin ↓AST, ↓ALT, ↓TB, ↓GGT In vivo (rats) [142] 
Kaempferol ↓AST, ↓ALT, ↓TB, ↓GGT In vivo (rats) [142] 
GI50 = 52.06 µg/mL  In vitro (HepG2 
cells) 
[139] 
Myricetin ↓AST, ↓ALT, ↓TB, ↓GGT In vivo (rats) [142] 
Quercetin ↓AST, ↓ALT, ↓MDA, ↑SOD, ↑GSH-Px In vivo (mice) [143] 
↓AST, ↓ALT, ↓TB, ↓GGT In vivo (rats) [142] 
Rutin ↓ALP, ↓ALT, ↓AST In vivo (wistar 
rats) 
[147] 
Alb – Albumin; ALP – alkaline phosphatase; ALT – Alanine transaminase; AST – Aspartate 
transaminase; BUN – Blood urea nitrogen; CAT – Catalase; DNA - deoxyribonucleic acid; GI50- Sample 
concentration that inhibited  50% of the net cell growth; GGT - &-glutamyltransferase; GSH – reduced 
glutathione; GSH-Px – Glutathione peroxidase; HBV – Hepatitis B; HDL – High-density lipoprotein; 
HepG2 – hepatocellular carcinoma line; LDL – Low-density lipoprotein; MDA – Malondialdehyde; PGT 
– Glutamic-pyruvic transaminase; SGPT - Serum glutamate pyruvate transaminase; SOD – Superoxide 
dismutase; SGOT – Serum glutamate oxaloacetate transaminase; TB – Total bilirubin; TC – Total 
cholesterol; TG – triglyceride; &-GTP – &-glutamyl transpeptidase.  
 
 37 
Table 6. Phenolic compounds from food sources with reported biological effects mainly related with antioxidant capacity and prevention of cardiovascular disease 
and cancer.  
Phenolic compound Source Reference 






Blackberry, blueberry, black grape, cherry, strawberry, red wine, plum [226,227] 
 
Condensed tannins Procyanidin Red wine, chocolate, cranberry juice and apples [228] 
Flavan-3-ols Catechin Fruits, vegetables, chocolate, lentil, green and black tea, wine, grapes and ginkgo [184,229-234] 
Flavanones Hespertin 
Naringenin 









Fruits, vegetables, and beverages such as tea and red wine [184,235-237] 
[177,178,238,239] 
Isoflavones Genistein Soy [240,241] 









Bioactivity  Reference 
Phenolic acids Commercial Infant cereals Antioxidant properties and 
aroma 
[246] 
Anthocyanins Cranberry (Vaccinium macrocarpon Ait.) Nutraceutical capsules Antioxidant activity [247] 
Isoflavones Soy (Glycine max L.) Dietary supplements Antimenopausial sympthoms [248] 
Phenolic extracts Blackberry (Rubus ulmifolius Schott) flowers Yogurt Antioxidant and antimicrobial 
activity 
[202] 
Borage (Borago officinalis L.) Fresh Pasta Antimicrobial activity [208] 
Chamomile (Matricaria recutita L.) flowers Cottage chesse and 
yogurt 
Antioxidant and antimicrobial 
activity 
[54,206] 
Fennel (Foeniculum vulgare Mill.) aerial parts Cottage chesse and 
yogurt 
Antioxidant and antimicrobial 
activity 
[55,206] 
Garcinia (Garcinia cowa Roxb) fruits Bread Antioxidant activity [199] 
Grape seed (Vitis vinífera L.) Yogurt Antioxidant activity [201] 
Green tea (Cammelia sinensis L.) Bread Antioxidant activity [200] 
Guava (Psidium guajava) flower Bread melanoidins Antioxidant activity [207] 
Pomegranate (Punica granatum L.) fruits Yogurt and pasta Antioxidant activity [196,197] 
Pomegranate (Punica granatum L.) peels Ice cream Antioxidant and aglucosidase 
inhibitory activities 
[198] 
Residues from brewing 
industry 
Meat Antioxidant and antimicrobial 
activity 
[249] 
Rosemary (Rosmarinus officinalis L.) Cottage cheese Antioxidant activity [205] 
 Suillus luteus (L.: Fries) Gray  and Coprinopsis atramentaria (Bull.) 
Redhead, Vilgalys & Moncalvo 
Cottage chesse Antioxidant activity [204] 
Veronicas (Veronica montana L.) Cream cheese Antibacterial activity [203] 
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Figure 1. Number of research articles and reviews, and patents published in the period from 1985 to 2016 regarding functional foods and phenolic compounds (obtained on 
web of science, July 2016; keyword: functional food and phenolic compounds).  
  
1985-1989 1990-1994 1995-1999 2000-2004 2005-2009 2010-2014 2015-2016
Articles 1 3 2 59 203 688 397



























Figure 3. Number of research articles and reviews, and patents published in the period from 1985 to 2015 regarding phenolic compounds and in vitro or in vivo assays 
(obtained on web of science, July 2016; keyword: phenolic compounds and in vitro; phenolic compounds and in vivo).  
1960-1964 1965-1969 1970-1974 1975-1979 1980-1984 1985-1989 1990-1994 1995-1999 2000-2004 2005-2009 2010-2014 2015-2016
in vitro article 2 9 2 11 17 26 72 164 364 950 2345 998
in vitro patents 4 3 1
in vivo article 0 1 3 20 28 31 82 110 221 370 839 323






















Figure 4. Beneficial effects of phenolic compounds. 
